CONCORD BIOTECH
|
The Current P/B Ratio of CONCORD BIOTECH is 13.44.
Share Price | ₹1,657.9 | May 02,2024 |
Market Cap | ₹17,341.1 Cr | |
Book Value | ₹1,290.0 Cr | Mar2023 - Consolidated Results |
Price/Book | 13.44x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of CONCORD BIOTECH
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹17,341.1 Cr] as on May 02,2024
(/) Book Value [ ₹1,290.0 Cr] based on Mar2023 - Consolidated Results
(=) P/B Ratio [ 13.44x ]
Thus, for CONCORD BIOTECH , the investors are currently willing to pay '13.44 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of CONCORD BIOTECH !
The chart below summarizes the trend in P/B Ratio of CONCORD BIOTECH over the last five years.
Historical PB (Price/Book ) ratio chart of CONCORD BIOTECH
PB Ratio Performance Analysis for CONCORD BIOTECH
- CONCORD BIOTECH 's p/b ratio for fiscal years ending Mar2023 to Mar2020 averaged 0.00x.
- CONCORD BIOTECH 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, CONCORD BIOTECH 's p/b ratio peaked in Mar2023 at 0x.
- CONCORD BIOTECH 's p/b ratio hit its five-year low in Mar2023 of 0x.
How does CONCORD BIOTECH 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
CONCORD BIOTECH | 1,290.00 | 13.44 | 17,341.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 55,995.40 | 6.51 | 364,315.0 |
CIPLA LTD | 23,346.00 | 4.91 | 114,614.0 |
DR REDDYS LABORATORIES LTD | 23,140.40 | 4.53 | 104,900.0 |
ZYDUS LIFESCIENCES LTD | 17,515.80 | 5.68 | 99,426.0 |
DIVIS LABORATORIES LTD | 12,767.10 | 8.24 | 105,233.0 |
MANKIND PHARMA LTD | 7,435.16 | 12.58 | 93,499.3 |
TORRENT PHARMACEUTICALS LTD | 6,198.07 | 14.60 | 90,493.5 |
LUPIN LTD | 12,315.60 | 6.10 | 75,096.2 |
AUROBINDO PHARMA LTD | 26,839.80 | 2.52 | 67,608.5 |
ABBOTT INDIA LTD | 3,146.02 | 17.97 | 56,532.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs CONCORD BIOTECH 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.52x |
Max industry PB | 17.97x |
Median industry PB | 6.51x |
Average industry PB | 8.82x |
You may also like the below Video Courses